Analyzing MariMed (OTC:MRMD) and GLG Life Tech (OTCMKTS:GLGLF)

GLG Life Tech (OTCMKTS:GLGLF) and MariMed (OTC:MRMD) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends.

Profitability

This table compares GLG Life Tech and MariMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GLG Life Tech	561.90%	N/A	-66.19%
MariMed	-8.95%	1.58%	0.53%

Valuation and Earnings

This table compares GLG Life Tech and MariMed”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GLG Life Tech	$7.64 million	0.00	-$4.17 million	$1.32	N/A
MariMed	$148.60 million	0.19	-$16.03 million	($0.03)	-2.42

GLG Life Tech has higher earnings, but lower revenue than MariMed. MariMed is trading at a lower price-to-earnings ratio than GLG Life Tech, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

0.2% of MariMed shares are owned by institutional investors. 19.0% of MariMed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for GLG Life Tech and MariMed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GLG Life Tech	0	0	0	0	0.00
MariMed	0	0	0	1	4.00

Given GLG Life Tech’s higher probable upside, research analysts clearly believe GLG Life Tech is more favorable than MariMed.

Volatility & Risk

GLG Life Tech has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, MariMed has a beta of 2.99, meaning that its share price is 199% more volatile than the S&P 500.

Summary

MariMed beats GLG Life Tech on 8 of the 12 factors compared between the two stocks.

About GLG Life Tech

GLG Life Tech Corporation researches for, develops, grows, refines, and produces natural sweeteners extracted from the stevia plant and monk fruit in Canada and internationally. It also offers P-Pro Plus, a pea protein product; REB M GOLD, a bioconverted Rebaudioside M and Rebaudioside D. sweetener; and natural ingredients. It serves in the food and beverage industry. The company was formerly known as GLG Life Tech Limited and changed its name to GLG Life Tech Corporation in March 2007. GLG Life Tech Corporation was incorporated in 1998 and is headquartered in Richmond, Canada.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.